Table 2.
Advantages and disadvantages of CAR-T Cells therapy in Multiple Myeloma.
Advantages | Disadvantages |
---|---|
Novel therapy for refractory/relapsed patients | Potentially can cause life-threatening complications |
Recognize cells without HLA expression | Relapses after treatment (antigen escape) |
Eliminates only cells with targeted antigen | Immunogenicity of CARs |
One-time treatment with long therapy-free intervals providing patients with a high quality of life | High costs of the therapy |